Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Medico Intercontinental Ltd - 539938 - Board Meeting Intimation for Intimation Of Board Meeting In Compliance Of Regulation 29, 30 And 33 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 Medico Intercontinental Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2019 ,inter alia, to consider and approve With reference to the captioned subject,we wish to inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Wednesday,29th May,2019 at the Administrative Ofc of the Company situated at 501, 5th Floor, Aditraj Arcade, Near Hetvi Tower,100 ft. Road, Satellite,Ahmedabad - 380015,to inter alia consider, approve and take on record the Audited Financial Results (Standalone and Consolidated)for quarter and financial year ended 31st March, 2019 and any other business items as per agenda circulated.
20-05-2019
Bigul

Medico Intercontinental Ltd - 539938 - Announcement under Regulation 30 (LODR)-Acquisition

 This is to inform the Exchange that pursuant to approval of members accorded in the Extraordinary General Meeting held on 23rd March, 2019, the Company has purchased all the shares of the Company and acquired the Company under the name and style of Azillian Healthcare Private Limited. Disclosures pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI circular No. CIR/CFD/CMD/4/2015 dated 9th September, 2015 are provided
09-05-2019
Bigul

Medico Intercontinental Ltd - 539938 - Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended 31St March, 2019.

 Please find enclosed herewith Compliance Certificate issued in terms of Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the half year ended on 31st March, 2019. You are requested to take the above information on record.
25-04-2019
Bigul

Medico Intercontinental Ltd - 539938 - Format of Initial Disclosure to be made by an entity identified as a Large Corporate

 Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayMedico Intercontinental Ltd 2CININE858Q01019 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Deepika Milan Undhad Designation: Company Secretary EmailId: mail@medicointercontinental.com Name of the Chief Financial Officer: PRADEEPBHAI KASTURBHAI MEHTA Designation: Chief Financial Officer EmailId: mail@medicointercontinental.com Date: 24/04/2019 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
24-04-2019
Bigul

Medico Intercontinental Ltd - 539938 - Declaration Pursuant To Circular Of SEBI / HQ / DDHS /CIR / P / 2018 / 144 Dated 26Th November. 2018 Reg. Fund Raising By Issuance Of Debt Securities By Large Entities

 With reference to above SEBI Circular of 26th November, 2018 in respect of fund raising by issuance of debt securities by [Large Corporates (LC) and disclosures and compliances thereof by such large corporates. In this connection, we submit that our Company Medico Intercontinental Limited is not coming under the Large Corporates (LC) category as per the framework provided in the aforesaid circular.
24-04-2019
Bigul

Medico Intercontinental Ltd - 539938 - Submission Of Compliance Certificate Pursuant To Regulation 40(9) Of The SEBI (Listing Obligation And Disclosure Requirement) Regulation, 2015 For The Half Year Ended 31St March, 2019.

 We are herewith enclosing Compliance Certificate, pursuant to Regulation 40(9) of the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015, issued by a Practicing Company Secretary for the Half Year ended 31st March, 2019. Kindly take the above on your records.
24-04-2019
Bigul

Medico Intercontinental Ltd - 539938 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015

 Pursuant to the provisions of regulation 8 of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, "Medico Intercontinental Limited - Code of practices and procedures for fair disclosure of Unpublished Price Sensitive Information" effective from 1st April, 2019 is available on the website of the Company. You are requested to kindly note the above.
18-04-2019
Bigul

Medico Intercontinental Ltd - 539938 - Shareholding for the Period Ended March 31, 2019

 Medico Intercontinental Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2019. For more details, kindly Click here
16-04-2019
Bigul

Medico Intercontinental Ltd - 539938 - Statement Of Investor Complaints For The Quarter Ended March 2019

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Deepika UndhadDesignation :- Company Secretary and Compliance Officer
11-04-2019
Bigul

Medico Intercontinental Ltd - 539938 - Announcement under Regulation 30 (LODR)-Change in Directorate

 Komal Bhagat - Company Secretary have tendered their resignation with immediate effect, due to personal reasons. The Board of Directors in their meeting held today at 3:30 p.m. have accepted their resignations and also approved the following matters: 1. Elected Mrs. Tanvi Shah as the new Chairman of the Company in place of Mr. Amar Jaiswal; 2. Appoint Ms. Deepika Kanabi as a Company Secretary and Compliance Officer of the Company. The disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 is herewith enclosed for your reference. The meeting concluded at 5:15 p.m.
08-04-2019
Next Page
Close

Let's Open Free Demat Account